• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: JOHNSON & JOHNSON SURGICAL VISION, INC. INTRAOCULAR LENS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

JOHNSON & JOHNSON SURGICAL VISION, INC. INTRAOCULAR LENS Back to Search Results
Model Number DIBOO
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Blurred Vision (2137); Dizziness (2194)
Event Date 12/29/2021
Event Type  Injury  
Event Description
Blur and distortion with distance vision - johnson & johnson tecnis eyhance (diboo) lens implanted after cataract surgery - overall vision is subpar, but driving has become extremely challenging.Doctor contends amd is my problem and that lens exchange will not improve my vision.However, j&j literature clearly states this kind of problem can develop in patients implanted with the diboo lens; i.E., the lens can seriously impair distance vision finding a competent physician to do the iol exchange is difficult and insurance does not want to cover the cost.Medicare and bcbs refuse to pay.Office visual acuity test turn out acceptable and is the reason insurance will not pay for an exchange.Visual acuity on the road cannot be measured, but can only be described as distortion seen in other automobiles on the road and blur to the extent i get dizzy and driving becomes dangerous.No office visual acuity test can demonstrate my problem.Fda safety report id #(b)(4).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
INTRAOCULAR LENS
Type of Device
INTRAOCULAR LENS
Manufacturer (Section D)
JOHNSON & JOHNSON SURGICAL VISION, INC.
MDR Report Key14160300
MDR Text Key289766912
Report NumberMW5109153
Device Sequence Number1
Product Code HQL
Combination Product (y/n)N
Reporter Country CodeUS
Number of Events Reported1
Summary Report (Y/N)N
Report Source Voluntary
Reporter Occupation Patient
Type of Report Initial
Report Date 04/14/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received04/18/2022
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Expiration Date12/29/2021
Device Model NumberDIBOO
Was Device Available for Evaluation? Yes
Patient Sequence Number1
Treatment
BUSPAR; CHORTRIMETON ALLERGY MEDICATION; LOSARTAN; PERSERVISION VITAMINS; TOPROL
Patient Outcome(s) Other;
Patient Age78 YR
Patient SexMale
Patient Weight82 KG
Patient EthnicityNon Hispanic
Patient RaceWhite
-
-